benzyl 4-(3-oxopropyl)piperidine-1-carboxylate | 775288-68-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: benzyl 4-(3-oxopropyl)piperidine-1-carboxylate
• CAS: 775288-68-1
• 化学式: C₁₆H₂₁NO₃
• 分子量: 275.348
• InChiKey: JQZHKBONFOQJTH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  benzyl 4-(3-oxopropyl)piperidine-1-carboxylate 在 三乙烯二胺 、 bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]} 、 三氟乙酸 作用下， 以 二氯甲烷 、 乙酸乙酯 为溶剂， 反应 1.0h， 生成 2-(8-((benzyloxy)carbonyl)-1,8-diazaspiro[4.5]decan-2-yl)acetic acid
  参考文献：
  名称：

  Synthesis of Unprotected Spirocyclic β-Prolines and β-Homoprolines by Rh-Catalyzed C–H Insertion

  摘要：

  A series of unprotected spirocyclic beta-prolines and beta-hornoprolines are prepared by Rh-catalyzed C-H insertion. The key intermediate, a Rh nitrenoid, is generated by the N-O bond cleavage of a substituted isoxazolidin-5-one. The reaction proceeds on a gram scale with a catalyst loading of as little as 0.1 mol %, affording spirocyclic beta-amino acids that are otherwise difficult to obtain. The building blocks prepared in this work will likely find applications in medicinal chemistry.

  DOI：

  10.1021/acs.orglett.9b03198
• 作为产物：
  描述：

  氯甲酸苄酯 在 盐酸 、 silica gel 、 pyridinium chlorochromate 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 4.0h， 生成 benzyl 4-(3-oxopropyl)piperidine-1-carboxylate
  参考文献：
  名称：

  [EN] ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE
  [FR] DÉRIVÉS D'ETHER D'ARYL ET D'HETEROARYLE EN TANT QU'AGONISTES DES RÉCEPTEURS Β X DU FOIE, COMPOSITIONS ET UTILISATION ASSOCIÉE

  摘要：

  式(I)中的取代芳基和杂环芳基醚化合物及其药用盐，其中X、R1、R2、R3、L、R4、L1、Q和R5如本文所定义。这些化合物和含有其化合物的药用组合物可用作肝X-β受体(LXRβ)激动剂，并可能用于治疗或预防与之相关的病理。这些病理包括但不限于炎症性疾病和以胆固醇和脂质代谢缺陷为特征的疾病，如阿尔茨海默病。

  公开号：

  WO2018068295A1

文献信息

• Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
  申请人：Barth Martine

  公开号：US20060178360A1

  公开（公告）日：2006-08-10

  The present invention concerns novel benzenesulphonamide compounds, defined by formula I and the description, their method of preparation and their use in therapy.

  本发明涉及新型苯磺酰胺化合物，由公式I和描述所定义，其制备方法及在治疗中的用途。
• SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
  申请人：Shanghai Leadingtac Pharmaceutical Co. Ltd.

  公开号：EP4328219A1

  公开（公告）日：2024-02-28

  Disclosed are an SOS1 degrading agent and a preparation method therefor and use thereof. Specifically, disclosed is a compound of formula I: S-L-E (I), wherein L is a linking chain, which links S and E by means of covalent bonds; E is a small molecule ligand of an E3 ubiquitin ligase complex. The compound of formula I of the present invention can degrade and/or inhibit SOS1 protein in cells, and can be used for the treatment and/or prevention of an SOS1-mediated disease or disorder, or a disease or disorder caused by the interaction of SOS1 with Ras or SOS 1 with Rac.

  本发明公开了一种SOS1降解剂及其制备方法和用途。具体地，公开了以下式I的化合物：S-L-E(I)，其中L为连接链，所述连接链通过共价键将S和E连接在一起；E为E3泛素连接酶复合物的小分子配体。本发明的式I化合物能够降解和/或抑制细胞内的SOS1蛋白，并可用于治疗和/或预防SOS1介导的疾病或异常，或由SOS1与Ras或SOS1与Rac相互作用引起的疾病或异常。
• ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE
  申请人：RUDD Michael T.

  公开号：US20200247754A1

  公开（公告）日：2020-08-06

  In its many embodiments, the present invention provides certain substituted aryl and heteroaryl ether compounds of the Formula (I): and pharmaceutically acceptable salts thereof, wherein X, R 1 , R 2 , R 3 , L, R 4 , L 1 , Q, and R 5 are as defined herein. The novel compounds of the invention, and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.